January 19, 2021
The Pharmaceutical Affairs and Food Sanitation Council’s drug safety panel agreed on January 15 that package inserts for Pfizer’s pulmonary arterial hypertension drug Revatio (sildenafil) and Sanofi’s arrhythmia med Ancaron (amiodarone) should advise caution rather than contraindicate the combined use...read more